
Stocks Slip as Pand...


| Price and Volume | |
|---|---|
| Recent Price | 14.59 |
| 52 Week High | 16.87 |
| 52 Week Low | 11.73 |
| Avg. Daily Vol. (Mil) | 0.63 |
| Beta (3 year) | 0.14 |
| Share Related Items | |
| Mkt Cap (Mil) | 1,401.96 |
| Shares Out (Mil) | 96.09 |
| Float (Mil) | 70.68 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 2.50 |
| Current Ratio | 4.10 |
| LT Debt/ Equity | 0.57 |
| Total Debt / Equity | 0.57 |
| Valuation Ratios | |
| Price Earnings | 37.40 |
| Price/Sales | 5.04 |
| Price/Book | 6.52 |
| Price/Cash Flow | 24.40 |
| Per Share Data | |
| Earnings | 0.39 |
| Sales | 2.90 |
| Book Value | 2.24 |
| Cash Flow | 0.60 |
| Business Summary | |
|---|---|
| Akorn, Inc. manufactures and markets a full line of diagnostic and therapeutic ophthalmic pharmaceuticals as well as niche hospital drugs and injectable pharmaceuticals. | |
| General Information | |
| 1925 W. Field Court
Suite 300 Lake forest, IL 60045 |
|
| www.akorn.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 976 | |
| CEO: Rajat Rai | |
| Short Interest | |
| Current Month (Mil) | 11.30 |
| Previous Month (Mil) | 11.84 |
| Short Interest Ratio (Days) | 21.40 |
| Management Effectiveness | |
| Return on Equity | 21.50 |
| Return on Assets | 12.10 |
| Return on Investments | 13.70 |
| Profitability | |
| Gross Margin | 57.90 |
| EBIT Margin | 28.00 |
| Profit Margin | 16.60 |